Opening Remarks from the Co-Chairs
Navigating the Perfect Storm Year: Assessing the Impact of Monumental Legal and Regulatory Developments in the Life Sciences on Intellectual Property Due Diligence

December 4, 2024 8:15am

Tom Irving
Partner
The Marbury Law Group, PLLC

Forrester Liddle
Head of IP and Legal, US R&D
Novo Nordisk

2024 has been a year of monumental developments in case law, policy, and regulations in the Life Sciences that have affected IP due diligence review. Hear from in-the-know practitioners on how the due diligence process has shifted, and how to ensure successful and thorough review processes, guiding you through the eye of the storm.